Aurinia Pharmaceuticals
biotech development and commercialization
AI Overview
With $113K in lobbying spend across 5 quarterly filings, Aurinia Pharmaceuticals is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $90K |
| 2019 | $23K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Aurinia Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Lupus
FDA approval of breakthrough therapies
Lupus
FDA approval of breakthrough therapies
drug pricing
drug pricing and coverage
lupus nephritis
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.